As the habitats in our analysis were used to inform the calibration of model parameters describing dynamics of tumor response to NAT, forming habitats with longitudinal data ensured that the habitats would capture regions of the tumor that experience similar changes in time, rather than capturing regions with distinct characteristics at a particular point in time. The gene discussed is BRD2; the disease is neoplasm.